Dietary Supplements (Claims and Labeling)

Center for Food Safety and Applied Nutrition sends FDA warning letter to CBD manufacturer of products for adults and kids – for adulteration/misbranding FD&C Act violations.

FDA sends out another warning letter to CBD companies that promote that company products for medical uses and for treating diseases will be in violation of the FD&A Act.

FDA labeling is one of the most important regulatory requirements for dietary supplements in that it provides the consumer the necessary information on the product. Indeed, ensuring that all [...]

Are physician online dietary supplement sales, kickbacks or fee-splitting?

Can a dietary supplement company link to scientific references that show that that the dietary supplement product is effective in treating a disease such as cancer, diabetes, or hypertension?

Because marketing and distributing dietary supplements carries FDA risk, we offer sample strategies to reduce FDA risk when selling dietary supplements.

New York's Attorney General initiated the investigation against major retailers of herbal supplements, based on DNA testing of plant materials suggesting contaminants, and mislabeling; was the [...]

Sales of dietary supplements by physicians, acupuncturists, chiropractors, and other licensed professionals raise thorny legal issues.

The FDA issued a warning letter citing a dietary supplement company for its online content.In its warning letter to dietary supplement manufacturer M.D.R. Fitness Corp., the FDA warned that [...]

Some states restrict the markup a physician can have on sales of dietary supplements. For example, New Jersey law has some relevant law.

The FTC Statement to Congress on Deceptive Marketing of Dietary Supplements is a good place to begin to understand legal compliance issues regarding marketing